ALC.7 Team Arthur J.E. Child Comprehensive Cancer Centre Wednesday, May 07, 2025 At the 2025 annual Spring Meeting of Participants the group presented the Phase III Program Team Award for an intergroup led trial to the ALC.7 team from Arthur J.E. Child Comprehensive Cancer Centre in recognition of their performance on the myeloMATCH master screening and reassessment protocol for people with acute myeloid leukemia or myelodysplastic syndrome. This award is presented to a non-MD team of clinical research associates, nurses, pharmacists and others who participated in a CCTG phase III clinical trial to acknowledge their efforts and dedication to the success of clinical trials. "We are so thrilled to be the recipients of this CCTG Phase III Team Award for our performance on the myeloMATCH ALC.7 trial. Our team put in tremendous effort, and we are thrilled to see the positive impact our work is having. This recognition fuels our commitment to continue making a meaningful difference in the lives of our patients", says Odukoya, Oluwaponmile on behalf of the team. Congratulations to the entire CCTG ALC.7 team at Arthur J.E. Child Comprehensive Cancer Centre: Oluwaponmile Odukoya, Berchman Wong, Chantal Poyser, Confidence Alex,Daniel Vera, Akeem Bello, Tulasi Rekha Boggarapu, Kim Stortz, Camille Piquette, Christina Irvine,Jessica Beresford, Nicole Dunse, Alia Ferrier, Chiemezie Ibegwam.
